HOXC10 promotes esophageal squamous cell carcinoma progression by targeting FOXA3 and indicates poor survival outcome

BACKGROUND: Esophageal cancer is one of the most unknown and deadliest cancers in the world. Although recent studies have identified some mutations linked to the development of squamous cell carcinoma of the esophagus (ESCC), the specific role of HomeoboxC10 (HOXC10) in the pathogenesis still requir...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Xiaoting, Wang, Huiyu, Wang, Runjie, Li, Yuting, Li, Suqing, Cao, Xiufeng, Xu, Junying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590975/
https://www.ncbi.nlm.nih.gov/pubmed/37876483
http://dx.doi.org/10.1016/j.heliyon.2023.e21056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590975/
https://www.ncbi.nlm.nih.gov/pubmed/37876483
http://dx.doi.org/10.1016/j.heliyon.2023.e21056

Ejemplares similares